Ohm Mucus Relief Tablet, Chewable
NDC Package 66096-706-23
Package Information
Ohm Mucus Relief (antimonium crudum, antimonium tartaricum, chelidonium majus, ferrum phosphoricum, kali carboonicum, kali muriaticum, kali sulphuricum, marrubium vulgare.) tablets is classified as a
- increased large intestinal motility - [pe] (physiologic effect)
- increased large intestinal motility - [pe] (physiologic effect)
- inhibition large intestine fluid/electrolyte absorption - [pe] (physiologic effect)
- osmotic activity - [moa] (mechanism of action)
- osmotic laxative - [epc] (established pharmacologic class)
- potassium compounds - [cs]
- potassium salt - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 66096 - Ohm Pharma Inc.
- 66096-706 - Ohm Mucus Relief
- 66096-706-23 - 186 TABLET, CHEWABLE in 1 BOTTLE
- 66096-706 - Ohm Mucus Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66096-706-23 identifies a specific commercial package of 186 tablet, chewable in 1 bottle of Ohm Mucus Relief, a human over the counter drug labeled by Ohm Pharma Inc.. This tablet, chewable is formulated for oral use and contains antimony potassium tartrate; antimony trisulfide; chelidonium majus; ferrosoferric phosphate; marrubium vulgare; potassium carbonate; potassium chloride; potassium dichromate; potassium sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on May 14, 2015. The current certification is valid through December 31, 2026.
How is this Ohm Pharma Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096070623. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.